In today’s briefing:
- L’Occitane (973 HK): Underlying Fundamentals Intact
- Globalfoundries Not Amused By TSMC’s European JV
- [Week 1] Namaste India 🙏 | Whirlpool Stock Performance Is Good, Earnings Are Not
- Trip.com Q223 Quick Take: Revenue, EPS > Consensus | Guidance? Not Much | Still No Upside Surprises
- Komatsu (6301) | A Winning Bet on Onshoring and Electrification
- Intel Does A Surprising Side Deal With Tower Semi
- China Longyuan (916 HK): Value Has Definitely Emerged
- Secure Trust Bank – One-off impairment masks underlying PBT beat
- Medtronic (MDT US): Q1 Result Exceeds Forecast; FY24 Guidance Raised on Higher Surgery Volumes
- 1Q Follow-Up – Takamiya (2445 JP)
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
L’Occitane (973 HK): Underlying Fundamentals Intact
- L’Occitane (973 HK) announced after market close yesterday that the controlling shareholder has terminated the potential general offer.
- Shares trade at a significant discount to global cosmetics peers and its own historical trading range, while brands’ growth momentum remain intact.
- Take advantage of any potential significant sell-down caused by the drop of the privatization attempt.
Globalfoundries Not Amused By TSMC’s European JV
- Globalfoundries may be considering filing a complaint regarding TSMC’s recently announced European JV with three of their customers, Bosch, Infineon and NXP
- Yet they just inked their own deal for a JV with ST Micro in France. What gives?
- In conjunction with their recent CFO hiring fiasco, one wonders if all is well with the GF leadership team.
[Week 1] Namaste India 🙏 | Whirlpool Stock Performance Is Good, Earnings Are Not
- Positive retail flows, HNI & AIF inflows, along with global market trends, suggest that the uptrend for the NIFTY Index (NIFTY INDEX) may continue.
- Bullish stocks include Metro Brands (METROBRA IN) and Zydus Wellness (ZYWL IN), while the sentiment for Whirlpool of India (WHIRL IN) is Bearish.
- Highlighted global stocks include Ebix (EBIX US) , Smith (A.O.) (AOS US) and Apple (AAPL US)
Trip.com Q223 Quick Take: Revenue, EPS > Consensus | Guidance? Not Much | Still No Upside Surprises
- Strong Q2 results out Tuesday morning beat consensus Revenue and core EPS estimates
- But concerns remain about expense control and longevity of ongoing demand recovery
- Great Q2 results, yes, but we think investors want more clarity about H2 demand
Komatsu (6301) | A Winning Bet on Onshoring and Electrification
- We turned bullish on Komatsu a year ago and the stock has since returned over 50%.
- Komatsu is trading at 10x EV/EBIT versus an historical average of 11x, with a target price of ¥5,100/share.
- Komatsu represents a cheaper way to play the theme of onshoring and long-term mining demand from electrification.
Intel Does A Surprising Side Deal With Tower Semi
- Tower Semi will pay Intel $300 million to acquire and own equipment and other fixed assets to be installed in the New Mexico facility
- Intel’s termination fee on the failure of the proposed Tower Semi acquisition was $353 million
- It’s quite the clever move and doesn’t require China’s approval…
China Longyuan (916 HK): Value Has Definitely Emerged
- China Longyuan Power (916 HK) is now attractively priced at 5.9x and 5.2x PERs for FY23 and FY24, respectively. The 2Q23 result clearly showed that business is gathering momentum.
- Margins have demonstrated good improvement despite weaker tariffs and coal sale business. With a very low base in last year, its 2H23 earnings growth will be impressive.
- There is positive progress on new project sign-up which has secured its pipeline. Asset injection from parent will stay as a major theme in the next two years.
Secure Trust Bank – One-off impairment masks underlying PBT beat
In its H123 results, Secure Trust Bank (STB) delivered an 11% y o y increase in operating income, overcoming margin pressure on rising interest rates. However, PBT was £16.5m, 4% lower than in H122 as the bank incurred a one-off impairment charge of £7.0m stemming from a long-standing debt case in Commercial Finance. Excluding this charge, PBT was £23.5m, which implies a 6% beat on our estimates on an annualised basis. Across the group, underlying impairments are resilient, especially in Vehicle Finance where impairments fell to 2.4% (H122: 8.0%) as lending shifted to prime borrowers. We have increased our FY23 and FY24 continuing PBT forecasts to £45m and £55m respectively, leaving the stock trading at P/E ratios of only 4.0x in FY23 and 3.1x in FY24.
Medtronic (MDT US): Q1 Result Exceeds Forecast; FY24 Guidance Raised on Higher Surgery Volumes
- Medtronic Plc (MDT US) announced better-than-expected Q1FY24 result. Revenue of $7.7B increased 6% on organic basis, ahead of guidance of 4.5%. Each of four segments delivered 6% organic revenue growth.
- Adjusted EPS increased 6% YoY to $1.20, ahead of guidance of $1.10–1.12. Outperformance was driven by better-than-expected operational performance and lesser-than-expected unfavorable impact from foreign currency translation.
- The company increased FY24 organic revenue growth guidance to 4.5% versus the prior range of 4.0% to 4.5% and adjusted EPS guidance to $5.08–5.16, 7 cent increase at midpoint.
1Q Follow-Up – Takamiya (2445 JP)
- Takamiya announced its 1Q results for FY24/3 on August 4, after the close of trading.
- Key figures on a consolidated basis were sales of ¥9,896 mn (+9.7% YoY), operating profit rose 125.5% YoY, to ¥409 mn, ordinary profit rose 41.0%YoY, to ¥615 mn, and quartery net profit rose 33.0%YoY, to ¥417 mn.
- An overview by business segment is as follows